Phase 3 clinical trials

Last revised by Henry Knipe ◉ ◈ on 17 Apr 2015

Citation, DOI, disclosures and article data

Citation:

Gaillard F, Knipe H, Phase 3 clinical trials. Reference article, Radiopaedia.org (Accessed on 03 Oct 2023) https://doi.org/10.53347/rID-30064

DOI:

https://doi.org/10.53347/rID-30064

Permalink:

https://radiopaedia.org/articles/30064

rID:

30064

Article created:

16 Jul 2014, Frank Gaillard ◉ ◈

Disclosures:

At the time the article was created Frank Gaillard had no recorded disclosures.

View Frank Gaillard's current disclosures

Last revised:

17 Apr 2015, Henry Knipe ◉ ◈

Disclosures:

At the time the article was last revised Henry Knipe had no recorded disclosures.

View Henry Knipe's current disclosures

Revisions:

3 times, by 2 contributors - see full revision history and disclosures

Tags:

Phase 3 clinical trials are the final hurdle to establishing a drug or experimental treatment is safe and effective. They are expensive and often long processes recruiting large numbers of individuals (e.g. 1,000 to 3,000). They are aimed at confirming Phase 2 findings (effectiveness and side-effects) as well as defining how effective this new treatment is compared to current management.

Related articles: Research

Promoted articles (advertising)

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

Unable to process the form. Check for errors and try again.

Thank you for updating your details.